|[December 03, 2013]
Oxygen Biotherapeutics to Host 2013 Annual Meeting of Shareholders
MORRISVILLE, N.C. --(Business Wire)--
Biotherapeutics, Inc., (NASDAQ: OXBT) a developer of oxygen-carrying
therapeutics, today announced it will webcast its 2013 Annual Meeting of
Shareholders on Wednesday, December 4, 2013 beginning at 9:00am ET at
the offices of Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan,
L.L.P. located at Wells Fargo (News - Alert) Capitol Center, 150 Fayettville Street,
Suite 2300, Raleigh, NC 27601. Oxygen Biotherapeutics' CEO John Kelley
and CFO Michael Jebsen will be hosting the call.
A listen only teleconference will be available in real-time by dialing
(877) 836-0197. To listen to the live webcast, please access the link https://event.webcasts.com/starthere.jsp?ei=1026689,
at least 15 minutes prior to register. A replay of the call will be made
available until June 4, 2014.
About Phyxius Pharma
Phyxius Pharma, Inc. is a privately-held development stage
pharmaceutical company. The company is focused on developing products
for use in acute care settings. The company has licensed North American
rights to develop and commercialize levosimendan from Orion Pharma,
Orion Corporation of Espoo, Finland.
About Oxygen Biotherapeutics, Inc.
Oxygen Biotherapeutics, Inc. is developing medical products that
efficiently deliver oxygen to tissues in the body. The company has
developed a proprietary perfluorocarbon (PFC) therapeutic oxygen carrier
called Oxycyte® that is currently in clinical and preclinical
studies for intravenous delivery for indications such as traumatic brain
injury, decompression sickness and stroke.
Caution Regarding Forward-Looking Statements
This news release contains certain forward-looking statements by the
Company that involve risks and uncertainties and reflect the company's
judgment as of the date of this release. The forward-looking statements
are subject to a number of risks and uncertainties, including, but not
limited to, delays in new product introductions and customer acceptance
of these new products, and other risks and uncertainties as described in
our filings with the Securities and Exchange Commission, including in
the current Form 10-Q filed on September 17, 2013, and our annual report
on Form 10-K filed on June 26, 2013, as well as other filings with the
SEC (News - Alert). The company disclaims any intent or obligation to update these
forward-looking statements beyond the date of this release. This caution
is made under the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995.
[ Back To Technology News's Homepage ]